(Q38730314)

5 September 2017

1 reference

title

Clinical pharmacokinetics of ceftriaxone (English)

1 reference

5 September 2017

1 reference

Yuk JH

1

1 reference

5 September 2017

Nightingale CH

series ordinal

2

1 reference

5 September 2017

Quintiliani R

series ordinal

3

1 reference

5 September 2017

publication date

1 October 1989

1 reference

Clinical Pharmacokinetics

5 September 2017

published in

1 reference

5 September 2017

volume

17

1 reference

5 September 2017

issue

4

1 reference

5 September 2017

page(s)

223-235

1 reference

Once-daily ceftriaxone for skin and soft tissue infections

5 September 2017

cites work

1 reference

12 December 2020

Variability of ceftriaxone pharmacokinetics in hospitalized patients with severe infections

1 reference

12 December 2020

Ceftriaxone treatment of multidrug-resistant Salmonella osteomyelitis.

1 reference

12 December 2020

International experiences with ceftriaxone in the treatment of lower respiratory tract infections

1 reference

12 December 2020

Comparative study of ceftriaxone and trimethoprim-sulfamethoxazole for the treatment of chancroid in Thailand.

1 reference

12 December 2020

Susceptibility of penicillinase-producing and non-penicillinase-producing strains of Neisseria gonorrhoeae isolated in Durban, South Africa, to 15 beta-lactam antibiotics

1 reference

12 December 2020

Ceftriaxone kinetics and cerebrospinal fluid penetration in infants and children with meningitis

1 reference

12 December 2020

Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis.

1 reference

12 December 2020

Ceftriaxone pharmacokinetics in the central nervous system

1 reference

12 December 2020

Single-dose ceftriaxone for chancroid

1 reference

12 December 2020

Comparative pharmacokinetics of ceftriaxone after subcutaneous and intravenous administration.

1 reference

12 December 2020

Ceftriaxone in the treatment of bacterial meningitis in children

1 reference

12 December 2020

Penetration of ceftriaxone into the liver

1 reference

12 December 2020

Transient formation of precipitations in the gallbladder associated with ceftriaxone therapy

1 reference

12 December 2020

Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin

1 reference

12 December 2020

Ceftriaxone given repeatedly cures manifest syphilis in the rabbit

1 reference

12 December 2020

Single-dose pharmacokinetics of ceftriaxone in infants and young children

1 reference

12 December 2020

Ceftriaxone or cefazolin prophylaxis for the prevention of infection after vaginal hysterectomy

1 reference

12 December 2020

Clinical Pharmacology of Ceftriaxone in Patients with Neoplastic Disease

1 reference

12 December 2020

Once daily ceftriaxone for central nervous system infections and other serious pediatric infections

1 reference

12 December 2020

Ceftriaxone therapy for asymptomatic neurosyphilis. Case report and Western blot analysis of serum and cerebrospinal fluid IgG response to therapy

1 reference

12 December 2020

Asymptomatic Chlamydia trachomatis urethritis in men.

1 reference

12 December 2020

Pharmacokinetics of ceftriaxone in patients with renal and liver insufficiency and correlations with a physiologic nonlinear protein binding model

1 reference

12 December 2020

Ceftriaxone effect on bilirubin-albumin binding

1 reference

12 December 2020

Ceftriaxone therapy for incubating and early syphilis

1 reference

12 December 2020

Successful treatment of gonococcal endocarditis with ceftriaxone

1 reference

12 December 2020

Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis

1 reference

12 December 2020

Comparative efficacy of ciprofloxacin and ceftriaxone in experimental arthritis caused by Escherichia coli

1 reference

12 December 2020

Effect of cephalosporins on bilirubin-albumin binding

1 reference

12 December 2020

Ceftriaxone in Haemophilus influenzae type b meningitis

1 reference

12 December 2020

Randomised observer blind comparative trial of ceftriaxone and penicillin in treating uncomplicated gonorrhoea in men and women

1 reference

12 December 2020

In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents

1 reference

12 December 2020

Intramuscular ceftriaxone in home parenteral therapy

1 reference

12 December 2020

Absolute Bioavailability of Ceftriaxone after Intramuscular Administration to Healthy Volunteers

1 reference

12 December 2020

Pharmacokinetics of Ceftriaxone in Pediatric Patients With Meningitis

1 reference

12 December 2020

Age-associated changes in ceftriaxone pharmacokinetics

1 reference

12 December 2020

Ceftriaxone pharmacokinetics during peritoneal dialysis

1 reference

12 December 2020

Pharmacokinetics of the third-generation cephalosporins.

1 reference

12 December 2020

Single-dose pharmacokinetics of ceftriaxone in patients with end-stage renal disease and hemodialysis

1 reference

12 December 2020

Clinical pharmacokinetics of the third generation cephalosporins

1 reference

12 December 2020

Pharmacokinetics and tolerance of ceftriaxone in humans after single-dose intramuscular administration in water and lidocaine diluents

1 reference

12 December 2020

Ceftriaxone therapy in bacteremic typhoid fever

1 reference

12 December 2020

Comparative study of ceftriaxone and spectinomycin in the treatment of uncomplicated gonorrhea in women

1 reference

12 December 2020

Antimicrobial therapy for Salmonella infections in the acquired immunodeficiency syndrome (AIDS)

1 reference

12 December 2020

Effect of ceftriaxone-induced alterations of bacteria on neutrophil bactericidal function

1 reference

12 December 2020

Ceftriaxone as effective therapy in refractory Lyme disease

1 reference

12 December 2020

Ceftriaxone kinetics after a single intravenous dose in leukemic children with fever and granulocytopenia

1 reference

12 December 2020

A pharmacokinetic and tolerance study of Ro13-9904, a new cephalosporin antibiotic

1 reference

12 December 2020

Outpatient treatment of serious community-acquired pediatric infections using once daily intramuscular ceftriaxone

1 reference

12 December 2020

Treatment of lower respiratory tract infections with ceftriaxone and cefotaxime. A comparative study.

1 reference

12 December 2020

Efficacy of ceftriaxone in treatment of serious childhood infections

1 reference

12 December 2020

Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment

1 reference

12 December 2020

Pharmacokinetics of intravenous and intraperitoneal ceftriaxone in chronic ambulatory peritoneal dialysis

1 reference

12 December 2020

Single-dose plasma and cerebrospinal fluid pharmacokinetics of ceftriaxone in infants and children

1 reference

12 December 2020

Activity of cefotaxime and ceftriaxone alone and in combination with penicillin, ampicillin and piperacillin against neonatal meningitis pathogens

1 reference

12 December 2020

Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus.

1 reference

12 December 2020

Multiple intravenous dose pharmacokinetics of ceftriaxone in man

1 reference

12 December 2020

Age and ceftriaxone kinetics

1 reference

12 December 2020

Penetration of ceftriaxone into human pleural fluid

1 reference

12 December 2020

Treatment of late Lyme borreliosis--randomised comparison of ceftriaxone and penicillin

1 reference

12 December 2020

Concentrations of ceftriaxone in gallbladder wall, bile, and serum in patients undergoing cholecystectomy.

1 reference

12 December 2020

Treatment of bacterial meningitis with once daily ceftriaxone therapy

1 reference

12 December 2020

Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitis

1 reference

12 December 2020

Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults

1 reference

12 December 2020

Penetration of 14C-Ro 13-9904 into tissue cage fluid in rabbits

1 reference

12 December 2020

Comparative study of ceftriaxone and cefuroxime for perioperative prophylaxis in orthopedic surgery

1 reference

12 December 2020

The pharmacokinetics of cefotaxime and ceftriaxone in renal and hepatic dysfunction

1 reference

12 December 2020

Comparative in vitro susceptibility of Treponema pallidum to ceftizoxime, ceftriaxone and penicillin G.

1 reference

12 December 2020

In vitro activity of cefonicid, ceforanide, and cefazolin against Staphylococcus aureus and Staphylococcus epidermidis and the effect of human serum

1 reference

12 December 2020

Clinical adverse effects during ceftriaxone therapy

1 reference

12 December 2020

Comparison of the β-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa

1 reference

12 December 2020

Efficacy of a twelve-hourly ceftriaxone regimen in the treatment of serious bacterial infections

1 reference

12 December 2020

Volume of distribution terms for a drug (ceftriaxone) exhibiting concentration-dependent protein binding. I. Theoretical considerations.

1 reference

12 December 2020

In vitro susceptibility of Salmonella to various antimicrobial agents, including a new cephalosporin, Ro 13-9904.

1 reference

12 December 2020

Displacement effect of ceftriaxone on bilirubin bound to human serum albumin

1 reference

12 December 2020

Oral neomycin and erythromycin compared with single-dose systemic metronidazole and ceftriaxone prophylaxis in elective colorectal surgery.

1 reference

12 December 2020

Diffusion of ceftriaxone (Ro 13-9004/001) in the cerebrospinal fluid. Comparison with other beta-lactam antibiotics in dogs with healthy meninges and in dogs with experimental meningitis

1 reference

12 December 2020

Pharmacokinetics of ceftriaxone after intravenous infusion and intramuscular injection

1 reference

12 December 2020

Single-dose ceftriaxone kinetics in functionally anephric patients

1 reference

12 December 2020

Ro 13-9904: A cephalosporin with a high degree of activity and broad antibacterial activity: an invitro comparative study

1 reference

12 December 2020

Treatment of uncomplicated gonorrhea with ceftriaxone: a review

1 reference

12 December 2020

Pharmacokinetics of ceftriaxone following intravenous administration of a 3 g dose

1 reference

12 December 2020

Biliary excretion and pharmacokinetics of ceftriaxone after cholecystectomy.

1 reference

12 December 2020

Biliary excretion of ceftriaxone

1 reference

12 December 2020

Ceftriaxone compared with a combination of ampicillin and chloramphenicol in the treatment of bacterial meningitis in adults.

1 reference

12 December 2020

Ceftriaxone pharmacokinetics following multiple intramuscular dosing

1 reference

12 December 2020

Ceftriaxone therapy in otolaryngological and pulmonary infections

1 reference

12 December 2020

Outpatient therapy of serious pediatric infections with ceftriaxone

1 reference

12 December 2020

Safety and efficacy of once daily ceftriaxone for the treatment of bacterial meningitis

1 reference

12 December 2020

Ceftriaxone versus combined gentamicin and clindamycin for polymicrobial surgical sepsis

1 reference

12 December 2020

CSF exchange after the erroneous intrathecal injection of 800 mg ceftriaxone for pneumococcal meningitis

1 reference

12 December 2020

Ceftriaxone: increasing the half-life and activity of third generation cephalosporins.

1 reference

12 December 2020

Diffusibility of the newer cephalosporins into human interstitial fluids

1 reference

12 December 2020

Single-dose ceftriaxone therapy of gonococcal ophthalmia neonatorum

1 reference

12 December 2020

Ceftriaxone transport through the blood-brain barrier

1 reference

12 December 2020

Human pharmacokinetics and distribution in various tissues of ceftriaxone

1 reference

12 December 2020

Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen

1 reference

12 December 2020

Correlation between structure and biological properties of cephalosporins: the discovery of ceftriaxone.

1 reference

12 December 2020

Comparative efficacies of single intravenous doses of ceftriaxone and ampicillin for shigellosis in a placebo-controlled trial

1 reference

12 December 2020

Ceftriaxone: a beta-lactamase-stable, broad-spectrum cephalosporin with an extended half-life

1 reference

12 December 2020

Ceftriaxone for treatment of primary syphilis in men: a preliminary study

1 reference

12 December 2020

Bilirubin displacement by ceftriaxone in neonates: evaluation by determination of 'free' bilirubin and erythrocyte-bound bilirubin

1 reference

12 December 2020

Pharmacokinetics of ceftriaxone in serum and gynecological tissues

1 reference

12 December 2020

Pharmacokinetics of ceftriaxone in humans

1 reference

12 December 2020

Pharmacokinetic profile of ceftriaxone in man.

1 reference

12 December 2020

Ceftriaxone in the treatment of serious infections, particularly after surgery

1 reference

12 December 2020

Randomised comparison of ceftriaxone and cefamandole therapy in lower respiratory tract infections in an elderly population.

1 reference

12 December 2020

Ceftriaxone therapy in adults with severe lower respiratory tract infections

1 reference

12 December 2020

Ceftriaxone therapy of meningitis and serious infections.

1 reference

12 December 2020

Plasma protein binding of ceftriaxone.

1 reference

12 December 2020

One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13-9904, a new parenteral cephalosporin. A dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order

1 reference

12 December 2020

Treatment of purulent meningitis with a new cephalosporin-Rocephin (Ro 13-9904). Clinical, bacteriological and pharmacological observations in 24 cases

1 reference

12 December 2020

Cefuroxime versus ceftriaxone prophylaxis in cardiovascular surgery

1 reference

12 December 2020

Single-dose therapy of gonococcal ophthalmia neonatorum with ceftriaxone

1 reference

12 December 2020

The penetration of ceftriaxone into synovial fluid of the inflamed joint

1 reference

12 December 2020

Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration

1 reference

12 December 2020

Pharmacokinetics of ceftazidime and ceftriaxone and their penetration into the ascitic fluid

1 reference

12 December 2020

Ceftriaxone: a third-generation cephalosporin

1 reference

12 December 2020

Emergence of ceftriaxone-resistant strains of Pseudomonas aeruginosa in cystic fibrosis patients.

1 reference

12 December 2020

Effects of concentration-dependent plasma protein binding on ceftriaxone kinetics.

1 reference

12 December 2020

Antimicrobial activity of ceftriaxone: a review

1 reference

12 December 2020

Difference in blister fluid penetration after single and multiple doses of ceftriaxone

1 reference

12 December 2020

Influence of ceftriaxone on natural defense systems

1 reference

12 December 2020

Volume of distribution terms for a drug (ceftriaxone) exhibiting concentration-dependent protein binding. II. Physiological significance.

1 reference

12 December 2020

Influence of serum protein binding and mode of administration on penetration of five cephalosporins into subcutaneous tissue fluid in humans

1 reference

12 December 2020

Ascitic fluid cephalosporin concentrations: influence of protein binding and serum pharmacokinetics

1 reference

12 December 2020

Comparison of ceftriaxone and ampicillin plus chloramphenicol for the therapy of acute bacterial meningitis

1 reference

12 December 2020

Comparison of once daily ceftriaxone with gentamicin plus cefuroxime for treatment of serious bacterial infections

1 reference

12 December 2020

Pharmacokinetics of Rocephin, a highly active new cephalosporin with an exceptionally long biological half-life

1 reference

12 December 2020

Delayed sterilization of Haemophilus influenzae type b meningitis with twice-daily ceftriaxone

1 reference

12 December 2020

Abnormal laboratory test values during ceftriaxone therapy

1 reference

12 December 2020

Single-dose ceftriaxone kinetics in the newborn

1 reference

12 December 2020

Single-dose ceftriaxone kinetics in liver insufficiency

1 reference

12 December 2020

10.2165/00003088-198917040-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

5 September 2017

1039981030

0 references

1 reference